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ABSTRACT
Objective: To estimate the impact and equity of
existing and potential UK salt reduction policies on
primary prevention of cardiovascular disease (CVD)
and gastric cancer (GCa) in England.
Design: A microsimulation study of a close-to-reality
synthetic population. In the first period, 2003–2015,
we compared the impact of current policy against a
counterfactual ‘no intervention’ scenario, which
assumed salt consumption persisted at 2003 levels.
For 2016–2030, we assumed additional legislative
policies could achieve a steeper salt decline and we
compared this against the counterfactual scenario that
the downward trend in salt consumption observed
between 2001 and 2011 would continue up to 2030.
Setting: Synthetic population with similar
characteristics to the non-institutionalised population of
England.
Participants: Synthetic individuals with traits
informed by the Health Survey for England.
Main measure: CVD and GCa cases and deaths
prevented or postponed, stratified by fifths of
socioeconomic status using the Index of Multiple
Deprivation.
Results: Since 2003, current salt policies have
prevented or postponed ∼52 000 CVD cases (IQR:
34 000–76 000) and 10 000 CVD deaths (IQR: 3000–
17 000). In addition, the current policies have
prevented ∼5000 new cases of GCa (IQR: 2000–7000)
resulting in about 2000 fewer deaths (IQR: 0–4000).
This policy did not reduce socioeconomic inequalities
in CVD, and likely increased inequalities in GCa.
Additional legislative policies from 2016 could further
prevent or postpone ∼19 000 CVD cases (IQR: 8000–
30 000) and 3600 deaths by 2030 (IQR: −400–8100)
and may reduce inequalities. Similarly for GCa, 1200
cases (IQR: −200–3000) and 700 deaths (IQR: −900–
2300) could be prevented or postponed with a neutral
impact on inequalities.
Conclusions: Current salt reduction policies are
powerfully effective in reducing the CVD and GCa
burdens overall but fail to reduce the inequalities
involved. Additional structural policies could achieve
further, more equitable health benefits.
BACKGROUND
Excess salt consumption is associated with
higher risk of cardiovascular disease (CVD)
and gastric cancer (GCa).1 2 Globally, more
than 1.5 million CVD-related deaths every
year can be attributed to the excess salt
intake.3 Further salt-related deaths come
from GCa. Health policies worldwide, there-
fore, aim to reduce dietary salt intake.4
Furthermore, the WHO recommends
reducing population exposure to salt as one
Strengths and limitations of this study
▪ Our study uses a technically advanced dynamic
microsimulation model that synthesises
information from the best available sources of
information on population exposures to salt,
and other non-communicable disease-related
risk factor.
▪ Many assumptions must be made with such
models; yet, in spite of the potential frailty of
such assumptions this model validated well
against observed cardiovascular disease and
gastric cancer incidence and mortality in real
populations, even when multiply stratified.
▪ The main assumption for the evaluation of
current policy was that the decline in salt con-
sumption observed since 2003 was fully attribut-
able to the implemented policy.
▪ We could not find a sufficiently large data set
with individual-level 24-hour urine sodium mea-
surements and other non-communicable
disease-related risk factor information. Therefore,
we developed a stochastic process to overcome
this and synthesise information from multiple
sources, which increased the overall uncertainty
of the model and is reflected in our reported
uncertainty estimates.
▪ To ensure transparency, we have made
IMPACTNCD source code open under GNU GPLv3
licence.
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of the ‘best buy’ strategies to prevent non-communicable
diseases, highlighting its cost-effectiveness and
feasibility.5
Since 2003, the UK has had one of the world’s most
successful salt reduction strategies, including public
awareness campaigns, food labelling and ‘voluntary’
reformulation of processed foods.6 The strategy compo-
nents and the evolution of the strategy over the years
have been described in detail elsewhere.7 8 This package
of measures is regularly evaluated and has been moni-
tored through nationally representative surveys using
24-hour urine collection measurements.9 Between 2001
and 2011, the mean salt consumption in the UK
dropped from 9.5 to 8.1 g/day10—a success, however,
still far from the national target of 6 g/day.11
In the UK, salt consumption is higher in more
deprived groups.12 13 Therefore, interventions aiming
to reduce salt consumption should ideally aim to
also reduce socioeconomic inequalities in health.
Unfortunately, the current UK strategy might potentially
increase socioeconomic inequality because awareness
campaigns, food labelling and voluntary reformulation
can be more effective among the more health conscious,
afﬂuent individuals.14–17 Indeed, evidence suggests the
socioeconomic gradient in salt consumption might have
worsened during the programme.13 18 In contrast, mod-
elling studies consistently suggest that more structural
interventions can be more effective, cost-effective and
equitable than the current UK policy.19 20
Structural salt reduction policies are usually based on
legislative initiatives like a mandatory reformulation of
processed foods or taxation of high-salt foods. Such
policies have already been adopted successfully in
Argentina, South Africa, Portugal, Hungary and else-
where, emphasising their feasibility.4 In fact, the actual
number of countries currently implementing legislative
measures has substantially increased since 2010,
indicating a global move towards stricter salt reduction
policies.4
The aim of this study was to estimate the impact
and equity of current UK salt reduction policy on
CVD and GCa burden since 2003. We further com-
pared current policy with other feasible policies to
estimate possible additional incidence and mortality
reductions.
METHODS
We used IMPACTNCD, a discrete time, dynamic, stochas-
tic microsimulation model to simulate the effect of
current policy and compare it to counterfactual scen-
arios. We split our analysis into two periods. The ﬁrst
corresponds to years 2003–2015, for which we compared
the potential beneﬁts of current policies against a null
intervention scenario. For the second period, 2016–
2030, we explored the potential beneﬁts of additional
structural salt reduction policies, assuming they might
lead to steeper declines in salt intake.
Model description
IMPACTNCD simulates synthetic individuals and allows
for greater ﬂexibility and more detailed simulation,
including different lag times between exposures and out-
comes, socioeconomic gradients in trends of risk factors
and a competing risk framework—a computationally
intensive task for which we employed the Farr Institute’s
statistical high-performance computing facilities.21
The model synthesises information from Ofﬁce for
National Statistics (ONS) regarding English population
structure by age, sex and socioeconomic status and the
Health Survey for England22 regarding exposure to CVD
and GCa-associated risk factors (see below) to generate
a close-to-reality synthetic population.23 Well-established
causal pathways between associated risk factors and
disease are used to translate exposure into CVD and GCa
incidence and mortality, in a competing risk framework.
Effect sizes were taken from published meta-analyses and
longitudinal studies (see online supplementary table S1).
For salt, we assumed a mediated effect through systolic
blood pressure on CVD incidence with 5-year mean lag
time, and a direct effect on GCa incidence with a mean
lag time of 8 years.
Outputs include CVD and GCa incidence and mortal-
ity in the synthetic population under different scenarios.
A detailed description of IMPACTNCD is provided in the
online supplementary Chapters S2-S4.
Risk factor modelling
The exposure of the synthetic population to salt was
informed by four nationally representative surveys
employing 24-hour urine collections between 2001 and
2011.10 24–26 We used a stochastic process to enhance
the information from these surveys with information
from spot urine measurements (see detailed description
in the online supplement Paragraph S3.3.2). Then, we
used quantile regression to project daily salt consump-
tion to 2030. Changes in salt consumption were trans-
formed to systolic blood pressure changes using the
metaregression equation of a meta-analysis of 103 trials.3
The ideal level of salt consumption is not clear (see
appendix Text S4 in Mozaffarian et al).3 We allowed
the level of ideal salt consumption under which no risk
exist to vary between 1.5 and 6 g/day with a mode of
3.8 g/day, following a PERT distribution.27
Trends of other CVD and GCa-associated risk factors
were also considered in this study by projecting the
observed in Health Survey for England trends since
2001, up to 2030. For CVD, body mass index, total
plasma cholesterol, diabetes mellitus (diagnosis or ele-
vated glycated haemoglobin/no diabetes), smoking
status (current/ex/never smoker), environmental
tobacco exposure (binary variable), fruit and vegetable
(portions/day) consumption, and physical activity (days
with at least 30 min of moderate or vigorous physical
activity/week) were included. Smoking duration, body
mass index, and less than two portions of fruit and vege-
table consumption were considered for GCa.28
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CVD was deﬁned as the sum of coronary heart disease
(CHD) and stroke (any type) cases. This study focuses
on primary prevention; hence, only the ﬁrst episode of
CHD, stroke and GCa was considered. The competing
risk framework allows individuals to develop CHD,
stroke or GCa independently, and die from these or any
other cause.
Model outputs
For this study, IMPACTNCD estimated the cumulative
cases prevented or postponed and deaths prevented or
postponed for the relevant period and for ages 30–84.
The results were stratiﬁed by quintile groups of Index of
Multiple Deprivation (QIMD), a relative measure of area
deprivation widely used in England.29 Inspired by the
slope index of inequality,30 we used two regression-based
metrics, the ‘absolute equity slope index’ and the ‘rela-
tive equity slope index’, as equity measures of a policy.
The former measures the impact of an intervention on
absolute inequality; for instance, a value of 100 means
100 more cases were prevented or postponed in most
deprived compared with least deprived areas, and abso-
lute inequality was decreased. The latter takes into
account pre-existing socioeconomic gradient of disease
burden and measures the impact of an intervention on
relative inequality; positive values mean the policy
tackles relative inequality and negative that the policy
generates relative inequality.
Owing to the assumed lag times, any changes in salt
exposure in the 2003 to 2015 period will reﬂect on CVD
incidence and mortality in years 2008 to 2020, and GCa
incidence and mortality in years 2011–2023. Similarly,
for the period 2016–2030, these changes will be
reﬂected in CVD burden in 2021–2035 and in GCa
burden in 2024–2038.
Uncertainty analysis
A probabilistic sensitivity analysis is incorporated in our
estimates, as IMPACTNCD implements a second-order
Monte Carlo approach that allows the estimated uncer-
tainty of model inputs to be propagated to the
outputs.31 We summarise the output distributions by
reporting medians and IQRs in the form of ﬁrst and
third quartiles. We also report the probability (Ps) that a
policy scenario aspect is superior to the counterfactual
one. For example, ‘100 cases prevented or postponed
(Ps=80%) in scenario A’ is interpreted as ‘in 80% of
Monte Carlo iterations, at least one case has been pre-
vented or postponed in scenario “A” comparing to the
counterfactual scenario’. Consequently, in the remaining
20% of iterations, cases in scenario ‘A’ were more than
in the counterfactual scenario. This does not mean that
scenario ‘A’ was harmful, but that its effect in those par-
ticular settings was not large enough to exceed the
‘noise level’ from other sources of uncertainty in the
model. For a detailed description of the sources of
uncertainty that were considered, please refer to the
online supplement Chapter S6.
Period 2003–2015 scenarios
Two scenarios were simulated. The ‘no intervention’
scenario assumes that no salt-related interventions were
implemented since 2003. Therefore, the salt exposure
remained stable at the estimated level of 2003 for the
period up to 2015. The ‘current policy’ scenario simu-
lates the decline in salt consumption that was observed
between 2003 and 2011, and projects it up to 2015,
assuming a logarithmic decline.
Period 2016–2030 scenarios
Here, we modelled the potential effect of structural,
legislative policies on salt intake, aimed to achieve feas-
ible and ideal targets. First, we modelled a ‘current
policy’ (baseline) scenario where the logarithmic decline
observed from 2003 to 2011 was projected up to 2030.
In a ‘feasible’ target scenario, we assumed that in
2016, policies like mandatory reformulation and/or tax-
ation of high-salt foods were implemented and as a
result, the mean salt consumption will gradually decline
to the national target of 6 g/day by 2020 for ages 19 to
64. Owing to lack of empirical evidence regarding the
magnitude of the impact of such policies on salt, we
allowed their target to vary between 5.8 and 7 g/day fol-
lowing a PERT distribution. The intervention was mod-
elled to be more effective for individuals with higher salt
consumption.
In an ‘ideal’ target scenario, we assumed mean salt
intake to reach the ideal salt intake 3.8 g/day by 2025
for ages 19–64. The ideal salt consumption was mod-
elled to vary between 1.5 and 6 g/day following a PERT
distribution. Similarly to the previous scenario, the inter-
vention was modelled to be more effective for indivi-
duals with higher salt consumption. The modelled
trends of salt consumption for all scenarios are depicted
in ﬁgure 1.
Other assumptions
We assumed that CVD and GCa case fatality is improving
by 5% and 2% annually, respectively, but the rate of
improvement diminishes by 1% (relative) every year.
Moreover, we assumed that there is a constant fatality
rate socioeconomic gradient of ∼5% by QIMD level
(halved for ages over 70) forcing the more deprived to
experience worse disease outcomes. These assumptions
are based on empirical evidence.32–35 Table 1 presents
the key modelling assumptions.
RESULTS
We present our results separately for the two distinct
periods, then an external validation of IMPACTNCD.
Evaluation of current policy (2003–2015)
Under the ‘current policy’ scenario, median salt con-
sumption was reduced from 8.9 (IQR: 8.7–9.2) g/day in
2003 to 7.1 (IQR: 6.9–7.2) g/day in 2015. Socioeconomic
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inequalities in salt consumption remained and might
even have increased as a result of the current policy.
Under the ‘no intervention’ scenario, IMPACTNCD
estimated ∼1.3 (IQR: 1.2–1.4) million new cases of CVD
and 700 000 (IQR: 680 000–720 000) deaths from CVD.
Likewise, the model estimated ∼68 000 (IQR: 61 000–
74 000) new GCa cases and 41 000 (IQR: 37 000–44 000)
deaths.
Compared with the ‘no intervention’ scenario, the salt
reduction strategy resulted in about 52 000 (IQR:
34 000–76 000; Ps=99%) fewer new CVD cases, and
10 000 (IQR: 3000–17 000; Ps=86%) fewer CVD deaths.
In addition, the current policy prevented around 5000
(IQR: 2000–7000; Ps=92%) new cases of GCa resulting
in 2000 (IQR: 0–4000; Ps=78%) fewer GCA deaths.
When equity was considered, we estimated that the
current policy has a rather neutral effect on tackling
socioeconomic inequalities in CVD. The effect on GCa
equity was more complex. Current policy apparently pre-
vented or postponed fewer GCa cases in more deprived
areas. However, GCa incidence increases with age and
more afﬂuent individuals tend to live longer. After dir-
ectly standardising age and sex, the effect was essentially
disappeared for absolute inequality bur remained for
relative inequality (table 2).
Future options (2016–2030)
Under the ‘current policy’ scenario, IMPACTNCD pro-
jected that median salt consumption would reduce
further from 7.0 (IQR: 6.8–7.7) g/day in 2016 to 6.2
(IQR: 5.9–6.2) g/day in 2030. The addition of structural
policies might reach the national target of 6 g/day by
2020. The less feasible ‘ideal’ policy scenario was esti-
mated to reach 3.6 (IQR: 3.0–4.1) g/day by 2030.
Inequality in salt consumption persisted under the
‘current policy’ projections and decreased moderately
with the addition of structural policies.
Under the ‘current policy’ scenario, we calculated ∼1.4
million new cases of CVD (IQR: 1.3–1.4 million) and
530 000 deaths (IQR: 510 000−560 000). Similarly, for
GCa we estimated some 80 000 new cases (IQR: 65 000
Table 1 IMPACTNCD key assumptions
Population module Migration is not considered.
Social mobility is not considered.
QIMD is a marker of relative area deprivation with several versions since 2003. We considered all
version of QIMD identical.
We assume all salt that is consumed is excreted from urine and all urine sodium comes from salt
consumption.
We assume that the surveys used are truly representative of the population.
We assume that the decline in salt consumption observed since 2003 was fully attributable to the
implemented policy.
Disease module We assume multiplicative risk effects.
We assume log-linear dose–response for the continuous risk factors.
We assume that the effects of the risk factors on incidence and mortality are equal and risk factors are
not modifying survival.
We assume 5-year mean lag time for CVD and 8-year for GCa (except for the cumulative effect of
smoking on GCa where lag was assumed similar to CVD one).
We assume 100% risk reversibility.
We assume that trends in disease incidence are attributable only to trends of the relevant modelled risk
factors.
Only well-accepted associations between upstream and downstream risk factors that have been
observed in longitudinal studies are considered. However, the magnitudes of the associations are
extracted from a series of nationally representative cross-sectional surveys (Health Survey for England).
For GCa, we assume that survival of 10 years after diagnosis equals remission.
CVD, cardiovascular disease; GCa, gastric cancer; QIMD, quantile group of Index of Multiple Deprivation.
Figure 1 Modelled trends of median salt consumption in
English population aged 30–84 under the four simulated
scenarios. Error bars represent IQRs.
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−93 000) and 42 000 deaths (IQR: 35 000−49 000).
Approximately 20 000 more cases of CVD and GCa can
be prevented or postponed from the implementation of
structural policies. Table 3 presents IMPACTNCD estimates
for the two counterfactual scenarios.
The addition of structural policies was more effective
among the most deprived groups especially for CVD
and might potentially decrease absolute socioeconomic
inequality (table 4). As anticipated, the ‘ideal’ scenario
had the largest impact on burden and inequality
(table 5).
Validation
We assessed the eternal validity of the IMPACTNCD
model by comparing the estimated number of deaths
from CVD and GCa against the observed number of
deaths from the same causes for years 2006 to 2013 in
England (ﬁgure 2). Detailed graphs by age group, sex,
QIMD and disease can be found in the online
supplement chapter S8. Overall, IMPACTNCD is strongly
validated even when mortality was highly stratiﬁed.
DISCUSSION
This is the ﬁrst study to quantify the impact of UK salt
reduction policies on CVD and GCa by socioeconomic
group. We estimated that the current UK salt strategy
has potentially prevented or postponed some 57 000
new cases and 12 000 deaths from CVD and GCa in
England. The addition of structural policies and
achievement on the national target by 2020 could
potentially prevent or postpone a further 20 000 new
cases and 4000 deaths, while the ‘ideal’ combination of
salt reduction policies might potentially prevent or post-
pone some 80 000 new cases and 14 000 deaths from
CVD and GCa.
When equity is considered, the impact of the imple-
mented strategy is more complex. Our results agree with
previous studies13 18 that the socioeconomic gradient in
salt consumption would not be reduced by these strat-
egies. IMPACTNCD estimated that current policies might
have a rather neutral impact of CVD socioeconomic
inequalities (absolute and relative) and worsen GCa
inequalities reﬂecting an older age distribution in more
afﬂuent groups. However, the addition of structural pol-
icies may reduce absolute socioeconomic inequality in
CVD incidence and neutralise the negative impact of
current policies on GCa inequalities.
Simpler modelling studies have previously examined
the impact of a theoretical decrease in UK salt consump-
tion. A 3 g/day reduction in salt consumption might
prevent about 32 000 CVD cases and 4500 CVD deaths
in England and Wales in a 10-year period according to
Barton et al,37 or 200 000 fewer CVD events and 90 000
fewer CVD deaths according to Dodhia et al38 or almost
100 000 fewer CVD deaths in 20 years according to
Hedriksen et al.39 Our results appear to echo the more
conservative estimates by Barton et al.37 In addition,
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Gillespie et al20 model that was informed by experts’
opinion to model policy effectiveness and equity esti-
mated that mandatory salt reformulation might reduce
socioeconomic inequalities in CHD. We reached reassur-
ingly similar conclusions using a very different
methodology.
Going further than previous studies, we modelled
structural interventions and as being more effective for
those individuals with the highest salt intakes. In the
UK, about 70% of dietary salt comes from processed
food.11 Since structural policies target processed foods,
their effect would be stronger among those with higher
consumption of processed food, and hence higher salt
intake.
Some researchers claim that salt consumption lower
than 7.5 g can actually increase the risk of CVD and
overall mortality.40 41 However, it appears that their argu-
ment is based on biased measurement methodology.
Previous studies that used the gold standard measure of
individual salt intake, multiple non-consecutive 24-hour
urine collections, to measure the salt exposure of their
participants have consistently suggested that the optimal
daily salt exposure is well below 6 g.42
Public health implications
Our study conﬁrms and quantiﬁes the positive impact of
the currently implemented UK salt reduction policies
on CVD and GCa disease burdens. The overall health
potential from salt reduction policies is likely to be
greater, for example, through kidney disease, which we
have not considered in our study. However, we also high-
light two culprits of current policy. First, the national
target of 6 g/day is unlikely to be reached in the next
15 years assuming the decline continues to be logarith-
mic. Second, the current policy will probably not reduce
socioeconomic inequalities in CVD incidence and might
even increase inequalities in GCa.
Structural policies, like a mandatory reformulation of
processed foods, could potentially accelerate the decline
in salt consumption and reduce absolute inequality in
CVD. The existing salt reduction recommendations for
the food industry could achieve the national target.9 In
order to realise this, however, the food industry must
comply with them, which is not happening at present.43
Failing to do so will most affect the poorest in society.
Although we did not consider cost in our study, previous
studies have suggested that mandatory reformulation is
cost-effective and potentially cost-saving.44 45
Many experts are supporting now the combined refor-
mulation in portion sizes, sugar, salt and fat content of
processed food with sanctions for food manufacturers
that do not comply.46 After the derail of the salt reduc-
tion strategy in 2011 due to the ‘Responsibility Deal’,
that transferred the responsibility for nutrition from the
Food Standards Agency to the food industry itself, salt
reduction efforts have been renewed since 2014.7 In
fact, the second year of the Public Health England sugar
reformulation programme is scheduled to also address
salt in 2017.47
Strengths and limitations
Our study uses a technically advanced microsimulation
model that synthesises information from the best avail-
able sources of information on population exposures to
salt, and other non-communicable disease-related risk
factor, to generate a ‘close-to-reality’ synthetic popula-
tion. Many assumptions must be made with such
models. Yet, in spite of the potential frailty of such
assumptions, this model validated well against observed
CVD and GCa incidence and mortality in real popula-
tions, even when multiply stratiﬁed. This validation is
particularly important because for the years after 2006
the incidence and mortality in the synthetic population
were recreated from ﬁrst epidemiological principles and
not through an optimisation process. Moreover, to
ensure transparency, we have made IMPACTNCD source
code open under GNU GPLv3 licence.
This study has many limitations, three of which are
noteworthy. First, for the evaluation of current policy, we
assumed that the decline in salt consumption observed
since 2003 was fully attributable to the implemented
policy. This was perhaps slightly simplistic and our esti-
mates may, therefore, be high. Second, we did not model
the effect of the ‘Responsibility Deal’ that potentially
reduced the rate of salt decline since 2011.7 43 However,
this overestimation of the baseline would, therefore,
reduce the apparent gains from additional structural pol-
icies, making our conclusions relatively conservative.
Third, we could not ﬁnd a sufﬁciently large data set with
individual-level 24-hour urine sodium measurements
and other non-communicable disease-related risk factor
information. The stochastic process we developed to
overcome this and synthesise information from multiple
sources increased the overall uncertainty of the model.
Nevertheless, this uncertainty has been quantiﬁed and
transparently reported using uncertainty intervals.
Table 3 Additional cases and deaths that can be potentially prevented or postponed (CPP, DPP) from the addition of
structural policies to current policy, and under the ‘ideal scenario’
Cardiovascular disease Gastric cancer
Scenario CPP in thousands DPP in thousands CPP in thousands DPP in thousands
Feasible 18.7 (8.0 to 29.5; Ps=90%) 3.6 (−0.4 to 8.1; Ps=72%) 1.2 (−0.2 to 3.0; Ps=72%) 0.7 (−0.9 to 2.3; Ps=63%)
Ideal 73.2 (53.9 to 94.3; Ps=100%) 11.0 (6.5 to 16.1; Ps=95%) 6.3 (3.4 to 9.6; Ps=94%) 3.1 (1.1 to 5.1; Ps=86%)
Compared with the current policy projections for 2015 to 2030.
Brackets contain the respective IQRs and the probability of superiority (Ps).
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Table 4 Additional effectiveness of structural policies compared with the ‘current policy’ scenario by quantile group of Index of Multiple Deprivation (QIMD)
‘Feasible’ scenario CPP absolute reduction in thousands CPP relative percentage reduction
QIMD CVD GCa CVD GCa
1 (least deprived) 2.7 (−1.0 to 6.4) 0.3 (−0.7 to 1.1) 1.6% (−0.5% to 3.6%) 2.6% (−6.2% to 10.3%)
2 2.4 (−1.2 to 6.6) 0.2 (−0.7 to 1.2) 1.3% (−0.7% to 3.6%) 2.4% (−6.6% to 10.4%)
3 2.8 (−1.0 to 6.8) 0.2 (−0.7 to 1.2) 1.5% (−0.7% to 3.6%) 2.4% (−7.0% to 10.2%)
4 2.8 (−1.3 to 7.0) 0.2 (−0.7 to 1.0) 1.6% (−0.7% to 3.9%) 2.2% (−7.5% to 11.2%)
5 (most deprived) 3.3 (−0.9 to 7.3) 0.3 (−0.7 to 1.2) 1.8% (−0.6% to 4.0%) 2.7% (−7.7% to 11.6%)
Slope 0.6 (95% CI 0.0 to 1.1) 0.0 (95% CI −0.1 to 0.2) 0.2% (95% CI −0.1% to 0.5%) 0.3% (95% CI −1.1% to 1.6%)
Slope (directly age and sex-standardised) 1.7 (95% CI 1.1 to 2.3) 0.1 (95% CI 0.0 to 0.2) 0.1% (95% CI −0.2% to 0.4%) −0.2% (95% CI −1.6% to 1.1%)
Absolute and relative reductions of cases prevented or postponed (CPP) are presented for cardiovascular disease (CVD) and gastric cancer (GCa).
The slope for absolute and relative reduction represents the absolute and relative equity slope index, respectively.
Brackets contain IQRs for the estimated CPP and 95% CIs for the slopes.
Table 5 The additional effectiveness of ‘ideal’ compared with the ‘current policy’ scenario by quantile group of Index of Multiple Deprivation (QIMD)
‘Ideal’ scenario CPP absolute reduction in thousands CPP relative percentage reduction
QIMD CVD GCa CVD GCa
1 (least deprived) 7.7 (3.3 to 12.6) 0.8 (−0.3 to 1.7) 4.2% (2.0% to 6.5%) 6.7% (−2.7% to 15.2%)
2 8.2 (3.6 to 12.6) 0.7 (−0.2 to 1.7) 4.1% (1.9% to 6.2%) 5.6% (−1.7% to 14.4%)
3 8.9 (4.0 to 14.4) 1.0 (−0.1 to 2.0) 4.4% (2.1% to 6.9%) 8.5% (−0.9% to 17.4%)
4 8.6 (3.5 to 13.3) 0.7 (−0.2 to 1.6) 4.4% (1.9% to 6.7%) 6.8% (−2.0% to 15.8%)
5 (most deprived) 9.7 (4.7 to 14.8) 1.0 (0.1 to 1.9) 4.9% (2.5% to 7.1%) 9.3% (1.0% to 18.4%)
Slope 2.1 (95% CI 1.4 to 2.8) 0.3 (95% CI 0.1 to 0.4) 0.8% (95% CI 0.5% to 1.2%) 3.4% (95% CI 2.0% to 4.7%)
Slope (directly age and sex-standardised) 5.7 (95% CI 5.0 to 6.3) 0.6 (95% CI 0.4 to 0.7) 0.7% (95% CI 0.3% to 1.0%) 2.9% (95% CI 1.5% to 4.3%)
Absolute and relative reductions of cases prevented or postponed (CPP) are presented for cardiovascular disease (CVD) and gastric cancer (GCa).
The slope for absolute and relative reduction represents the absolute and relative equity slope index, respectively.
Brackets contain IQRs for the estimated CPP and 95% CIs for the slopes.
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CONCLUSIONS
Current salt reduction policies are generally effective in
reducing the cardiovascular and cancer disease burden
but fail to do so equitably. Additional structural policies
could achieve further, more equitable health beneﬁts.
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